168th Session of the Executive Committee

Virtual Session, 21-25 June 2021

168th Session of the Executive Committee

The Executive Committee is composed of nine Member States of the Organization, elected by the Conference or the Council for overlapping periods of three years. The Committee, which meets twice a year, acts as a working party of the Conference or Council. Special meetings are convoked by the Director of the Bureau either on his/her own initiative or upon request of at least three Member States. The Committee has an auxiliary advisory body, the Subcommittee on Program, Budget, and Administration.


Final Report

Official Documents

  • OD362
    - Financial Report of the Director and Report of the External Auditor for 2020

Working Documents

  • CE168/1, Rev. 2
    - Agenda
  • CE168/2
    - Representation of the Executive Committee at the 59th Directing Council of PAHO, 73rd Session of the Regional Committee of WHO for the Americas
  • CE168/3, Rev. 1
    - Draft Provisional Agenda of the 59th Directing Council of PAHO, 73rd Session of the Regional Committee of WHO for the Americas
  • CE168/4
    - Report on the 15th Session of the Subcommittee on Program, Budget, and Administration 
  • CE168/5
    - PAHO Award for Health Services Management and Leadership 2021
  • CE168/5, Add. I
    - PAHO Award for Health Services Management and Leadership 2021
  • CE168/6
    - Non-State Actors in Official Relations with PAHO
  • CE168/7
    - Appointment of One Member to the Audit Committee of PAHO
  • CE168/8
    - Proposed Program Budget of the Pan American Health Organization 2022-2023
  • CE168/8, Add. I
    - Proposed Program Budget of the Pan American Health Organization 2022-2023
  • CE168/8, Add. II
    - Proposed Program Budget of the Pan American Health Organization 2022-2023
  • CE168/9
    - Scale of Assessed Contributions 2022-2023
  • CE168/10
    - Roadmap for the Digital Transformation of the Health Sector in the Region of the Americas
  • CE168/11
    - Policy on the Application of Data Science in Public Health Using Artificial Intelligence and Other Emerging Technologies
  • CE168/12
    - Increasing Production Capacity for Essential Medicines and Health Technologies 
  • CE168/13, Rev. 1
    - One Health: A Comprehensive Approach for Addressing Health Threats at the Human-Animal-Environment Interface  
  • CE168/14
    - Reinvigorating Immunization as a Public Good for Universal Health  
  • CE168/15
    - Strategy for Building Resilient Health Systems and Post COVID-19 Pandemic Recovery to Sustain and Protect Public Health Gains
  • CE168/16
    - Report on the Collection of Assessed Contributions
  • CE168/16, Add. I
    - Report on the Collection of Assessed Contributions
  • CE168/17
    - Appointment of the External Auditor of PAHO for 2022-2023 
  • CE168/18
    - Update on the Master Capital Investment Fund  
  • CE168/19
    - Update on the Working Capital Fund
  • CE168/20
    - Report on the Status of the Emergency Loan from the Revolving Fund for Access to Vaccines to the Regional Revolving Fund for Strategic Public Health Supplies
  • CE168/21
    - Amendments to the PASB Staff Regulations and Rules
  • CE168/22
    - PASB Human Resources Management  
  • CE168/23
    - Statement by the Representative of the PAHO/WHO Staff Association

Information Documents

  • CE168/INF/1
    - Update on COVID-19 in the Region of the Americas
  • CE168/INF/2
    - Report on Strategic Issues between PAHO and WHO
  • CE168/INF/3
    - Implementation of the International Health Regulations

*Due to the COVID-19 pandemic and as agreed by the Officers of the Executive Committee, the following reports are published for information only.

Resolutions

  • CE168.R1
    - Collection of Assessed Contributions
  • CE168.R2
    - Policy on the Application of Data Science in Public Health Using Artificial Intelligence and Other Emerging Technologies
  • CE168.R3
    - Roadmap for the Digital Transformation of the Health Sector in the Region of the Americas
  • CE168.R4
    - Increasing Production Capacity for Essential Medicines and Health Technologies
  • CE168.R5
    - Scale of Assessed Contributions 2022-2023
  • CE168.R6
    - Proposed Program Budget of the Pan American Health Organization 2022-2023
  • CE168.R7
    - Assessed Contributions of the Member States, Participating States, and Associate Members of the Pan American Health Organization for 2022-2023
  • CE168.R8
    - PAHO Award for Health Services Management and Leadership 2021
  • CE168.R9
    - Appointment of One Member to the Audit Committee of PAHO
  • CE168.R10
    - Emergency Loan from the Revolving Fund for Access to Vaccines to the Regional Revolving Fund for Strategic Public Health Supplies
  • CE168.R11
    - One Health: A Comprehensive Approach for Addressing Health Threats at the Human-Animal-Environment Interface
  • CE168.R12
    - Strategy for Building Resilient Health Systems and Post COVID-19 Pandemic Recovery to Sustain and Protect Public Health Gains
  • CE168.R13
    - Amendments to the PASB Staff Regulations and Rules
  • CE168.R14
    - Non-State Actors in Official Relations with PAHO
  • CE168.R15
    - Reinvigorating Immunization as a Public Good for Universal Health
  • CE168.R16
    - Provisional Agenda of the 59th Directing Council of PAHO, 73rd Session of the Regional Committee of WHO for the Americas

Diverse Documents